Alto Neuroscience, Inc. Liquidation Value

ANRO Other

Cash & Equivalents

$176.48M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $176.48M
Total Obligations: -$32.47M
$144.01M
Per share: $4.51
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $176.48M
AR: $0
Total Obligations: -$32.47M
$144.01M
Per share: $4.51
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $176.48M
AR: $0
Inventory: $0
Total Obligations: -$32.47M
$144.01M
Per share: $4.51
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$144.01M$4.51
Liquid Liquidation Value$144.01M$4.51
Operating Liquidation Value$144.01M$4.51

Key Components (as of 2025-12-31)

Cash & Equivalents$176.48M
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$11.32M
Long-term Debt$16.17M
Op. Lease Liability$4.97M
Finance LeaseN/A
Shares Outstanding31.9M

Explore all 150 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$176.48MN/AN/A$1.88M$11.32M$16.17M$4.97MN/A
2025-09-30$137.82MN/AN/A$2.06M$9.04M$20.31M$5.08MN/A
2025-06-30$147.59MN/AN/A$1.67M$8.13M$20.12M$5.19MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-16 View
2025-09-30 10-Q 2025-11-12 View
2025-06-30 10-Q 2025-08-13 View
2025-03-31 10-Q 2025-05-14 View
2024-12-31 10-K 2025-03-20 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-13 View
2024-03-31 10-Q 2024-05-14 View

Community Notes

Loading notes...

Questions

Loading questions...